Applied DNA Accepted Into U.S. FDA's Emerging Technology Program, Creating Pathway for Molecular Tagging of Pharmaceuticals and Packaging – Business WireBy / April 30, 2020 Applied DNA Accepted Into U.S. FDA’s Emerging Technology Program, Creating Pathway for Molecular Tagging of Pharmaceuticals and Packaging Business Wire Share this:TweetReddit
